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We enjoyed reading Jordan Raff’s My
word article [1], in which he expressed
dismay at the lack of interest the
British public take in science and
contrasted this with his experiences
in the US. He also indicated that local
politicians and school children did not
visit scientific institutions in the UK
and that his colleagues were less than
enthusiastic when confronted with
the idea that such visits might be
organised. This may be the case in
Cambridge, and perhaps in many
other centres in the UK, but the
situation is so different in Dundee
that we have felt obliged to respond.
Indeed, the enthusiasm and support
of the local community for our
activities is one of the reasons why
we continue to live and work here.
We have numerous visits from
local politicians, with whom we are on
first-name terms. When one of us
arrived in Dundee, the Lord Provost
(the ceremonial figurehead of the
city) came to visit, and said “Please
wheel me out whenever you need
me.” Even the Secretary of State for
Scotland came to see us recently. Our
local MPs are active in taking up our
concerns about issues like the time
taken to get work permits for overseas
staff, lack of funding for particular
areas of science and low pay, and we
are invited to many of the social
events that take place in the city.
Hardly a day goes by without the
local newspaper running a story about
the scientific achievements of our
staff and/or developments in the
emerging Dundee biotech industry.
Local TV and radio stations regularly
interview staff and there have been
several in-depth articles in the
national newspapers about our work.
Since the Biomedical Research
Centre and the Wellcome Trust
Biocentre opened in Dundee, both
places have been inundated with
(unsolicited) requests to visit each
building from local businesses,
women’s groups and even churches.
We have had several visits from local
schools, and Dundee High School
made the Biomedical Research
Centre the theme of its young
enterprise initiative. One of us was
asked to present the prizes at a local
high school and another to open a
science festival in one of the local
primary schools. For the past two
years we have participated in ‘Open
Doors Day’, in which buildings in
the city are opened to the general
public on one Saturday a year. These
have been so popular that we have
had to put a cap on the numbers.
The presence in the city of five
research groups funded by the Cancer
Research Campaign and two by the
Imperial Cancer Research Fund has
created a huge local interest in cancer
research. During the past five years,
more than £5 million have been raised
locally in three separate appeals to
support ICRF and CRC activities and
to enable one of us (D.P.L) to make
stronger links with the clinical
oncologists in Dundee University
Medical School. This is a remarkable
sum of money for a town with only
150,000 inhabitants.
Two of us have been awarded the
Dundee Rosebowl, which is given
annually to the person deemed to
have done most to enhance the
prestige of the city. Previous winners
include Liz McColgan (the former
world 10,000-metre champion and
winner of the London and New York
Marathons), and the Dundee United
Football Team. One of us was voted
Scottish Scientist of the Year in a poll
of (non-scientist) readers conducted
by the Daily Mail. Even more
remarkably, the rooms in a new
conference centre at a local hotel
have been named after prominent
Dundee biomedical scientists.
In summary, our experience is that
the local community takes a great
interest and pride in the success of
biomedical science in Dundee, and
the prestige and greater prosperity it
brings to the city. More than 500 new
jobs have been created in biomedical
and life sciences in Dundee over the
past five years — bringing the total to
1,600 — and Scottish Enterprise has
estimated the current value of this
sector to the local economy at
£23 million per year.
We don’t know whether these
experiences contrast with those of
Jordan Raff because of a North–South
divide, or whether Cambridge (which
is about the same size as Dundee) has
become blasé about its university and
the science done there. We heartily
agree with Jordan’s contention that all
scientists must make a much greater
effort to interact with the general
public, to interest them in science and
to explain the benefits it brings to the
community. The public are actually
really interested in science but find it
rather daunting until it is explained to
them in simple terms. Our excellent
relations with the citizens of Dundee
have been built up over many years
and this has required a commitment
from scientists and non-scientists
alike. Translating this success to the
national level (so that even Jordan
Raff becomes loved!) is now the
urgent task.
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Chlamydiae are major human
pathogens and the etiological agents
of several diseases in humans, other
mammals and birds. Depending on
Magazine R911
the serotype, infection with
Chlamydiae trachomatis can result in
trachoma, sexually-transmitted
diseases or inclusion conjunctivitis
[1]. A second chlamydial species,
C. pneumoniae, is associated with
upper respiratory tract infections [2].
Following internalisation by
eukaryotic cells, chlamydiae are
enveloped within membrane-bound
compartments, or inclusions, that do
not fuse with lysosomes [3]. Multiple
chlamydiae in a eukaryotic cell fuse
their inclusions into a single large
inclusion that contains the infectious
but metabolically-inactive elementary
body (EB). EBs differentiate into
replicative, reticulate bodies (RBs)
6–8 hours postinfection. RBs
eventually revert to EBs and are
released from the host cell to continue
the infectious process.
The complete genome sequences
of C. trachomatis [4] and
C. pneumoniae [5] have been recently
determined. After the predicted
protein sequences of C. trachomatis




automatically predicted that the
C. trachomatis hypothetical protein
CT153 contains a MACPF domain.
This domain is present in
mammalian membrane-attack
complex and perforin proteins [7,8],
but had not been previously
identified in non-eukaryotic proteins.
The associated statistical significance
of this prediction (E = 7.5 × 10–3) was
corroborated using PSI-BLAST
[9,10] database searches with an E-
value inclusion threshold of 0.001.
For example, two rounds of a PSI-
BLAST search using the human
complement component 9 MACPF
domain sequence (amino acid
residues 138–503) as the query
resulted in identification of the
C. trachomatis CT153 protein as
significantly similar to this domain
with an E-value of 3 × 10–7. 
Further investigation of this
domain family revealed a MACPF
domain in other eukaryotic proteins
(Figure 1). These included the
vertebrate central nervous system
gene, astrotactin, which is involved
in neuronal migration [11] (see figure
legend for details). Given the known
functions of MACPF domains
(discussed below), this finding
suggests that the astrotactin MACPF
interacts directly with the cellular
membranes of migrating neurons. No
bacterial MACPF-domain-containing
proteins, other than C. trachomatis
CT153 and its presumed orthologue
in C. pneumoniae, were identified in
database searches. 
Given what is known about
MACPF domains in eukaryotic
proteins, what might be the
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Figure 1
Multiple alignment of MACPF domain
sequences. Amino acid residues are coloured
according to an 80% consensus (calculated
using the website Consensus http://www.
bork.embl-heidelberg.de/Alignment/consensus.
html; Brown N., Lai J.): a, aromatic residues (F,
H, W and Y, highlighted in yellow); b, big
residues (E, F, I, K, L, M, Q, R, W and Y,
indicated in grey or yellow); h, hydrophobic
residues (A, C, F, H, I, L, M, V, W and Y,
highlighted in yellow); l, aliphatic residues (I, L
and V, highlighted in yellow); p, polar residues
(D, E, H, K, N, Q, R, S and T, coloured in blue);
s, small residues (A, C, S, T, D, N, V, G and P,
coloured in green); and u, tiny residues (A, G
and S, coloured in green). Residues that are
conserved in more than 80% of sequences
are shown as white-on-black. An arrow
indicates the glycine residue in human C7 that
is substituted by arginine in patients with C7
deficiency [22]. Residues excised from the
alignment are indicated by numbers. The 54-
residue region in C9 that is not aligned in the
figure contains its species-selective CD59
recognition site bound by two disulphide-
linked cysteines present also in perforin, C6,
C7, C8a and C8b [23]. Predicted [24]
secondary structures are indicated below the
alignment (e/E, extended or β-strand structure;
h/H helix); lowercase letters represent
predictions that have expected accuracies of
> 72%, and uppercase letters represent
predictions that have expected accuracies of
> 82%. Residue numbers and GenPept
identifiers are shown following the alignment.
Abbreviations: Compl., Complement;
Hypothetical, human hypothetical protein
(dJ1026E2.C1.1) from 1q24.1–1q25.3;
Mpg-1, macrophage specific gene 1; At,
Arabidopsis thaliana; Cp, Chlamydia
pneumoniae; Ct, Chlamydia trachomatis; Dm,
Drosophila melanogaster; En, Emericella
nidulans; He, Heliocidaris erythrogramma; Hs,
Homo sapiens; and Mm, Mus musculus. A
PSI-BLAST [9,10] database search with the
human complement component 6 MACPF
domain sequence (amino acid residues
176–516) revealed significant similarity
(E = 5 × 10-3) to a human astrotactin-like
molecule (KIAA0634) by round 4, using an
E-value inclusion threshold of 0.01. In addition,
chlamydial CT153 homologues, astrotactin
homologues and Drosophila torso-like [25]
were identified within four iterations in a MoST
[26] search using a region (overlined) that
included the conserved helix II region of
vertebrate MAC and perforin proteins [12],
and an E-value inclusion threshold of 0.05. A
revised multiple alignment of MACPF
sequences is available from SMART. 
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Hypothetical Hs YREFARWKVNNLALERKDFFSLPLPLAPEFIRNIRLLGRRPNLQ------QVTENLIKKYGTHFLLSATLGGEESLTIFVDKQKLGRK(42)
                                                                   __________________________________
CT153        Ct KNTVTCSTAAHSLYTLKEDD-SSNPSEKRLDSCFRNWIENKLSANSPD---SWSAFIQKFGTHYIASATFGGIGFQVLKLSFEQVEDL(36)
CT153        Cp KNTVTHSTASRTLYILRQDC-SYDPRALKVDDEFRYWVEKRLDAKNPD---SLNAFVKEVGTHYVASVTYGGIGFQVLKMSYLQVEEL(36)
Perforin     Mm QYNFNSDTVECRMYSFRLVQ--KPPLHLDFKKALRALPRNFNSSTEH----AYHRLISSYGTHFITAVDLGGRISVLTALRTCQLTLN(51)
Perforin     Hs QYSFSTDTVECRFYSFHVVH--TPPLHPDFKRALGDLPHHFNASTQP----AYLRLISNYGTHFIRAVELGGRISALTALRTCELALE(51)
Compl. C6    Hs SFIRIHKVMKVLNFTTKAK---DLHLSDVFLKALNHLPLEYNSA-------LYSRIFDDF YFTSGSLGGVYDLLYQFSSEELKNS(50)
Compl. C7    Hs QLLVVENTVEVAQFINNNPE--FLQLAEPFWKELSHLPSLYDYS-------AYRRLIDQYGTHYLQSGSLGGEYRVLFYVDSEKLKQN(45)
Compl. C8a   Hs IFTRIFTKVQTAHFKMRKD---DIMLDEGMLQSLMELPDQYNYG-------MYAKFINDYGTHYITSGSMGGIYEYILVIDKAKMESL(53)
Compl. C8b   Hs VFLHARSDLEVAHYKLKPR---SLMLHYEFLQRVKRLPLEYSYG-------EYRDLFRDFGTHYITEAVLGGIYEYTLVMNKEAMERG(54)
Compl. C9    Hs MFLHVKGEIHLGRFVMRNR---DVVLTTTFVDDIKALPTTYEKG-------EYFAFLETYGTHYSSSGSLGGLYELIYVLDKASMKRK(54)
T22A6.120    At TKNLAFDGVFISLYSVALD----KSQVLLREHVKQAVPSTWDPA-------ALARFIDIYGTHIIVSVKMGGKDVIYAKQ-QHSSKLQ(45)
Mpg-1        Mm QAVTTRVQVRNRIYTVKTTP--TSELSLGFTKALMDICDQLEKNQTKMATYLAELLILNYGTHVITSVDAGAALVQEDHV-RSSFLLD(44)
SpoC1-C1C    En GLWSIGDLNYTVQFDMQSL---ERCINADFIWAARRLPCWDENDASAR--DAFAKFFATWGTHVTTGCCLGARYQLQVTRPDASDESK(35)
Apextrin     He QTIQNFGHMRYLTSLAEHD---GFEIAREFRIDVCDLPTTYATN-------TYMEFLSKWGTSVVTEADVGVRTGINSREDRSSFVKD(55)
KIAA0634     Hs YPMVQQWRVRSNLYRVKLS---TITLAAGFTNVLKILTKESSRE-------ELLSFIQHYGSHYIAEALYGSELTCIIHFPSKKVQQQ(35)
Astrotactin  Hs YPVLQHWKVRSVMYHIKLN---QVAISQALSNALHSLDGATSRA-------DFVALLDQFGNHYIQEAIYGFEESCSIWYPNKQVQRR(39)
Torso-like   Dm YSYVLVRVVRFRETGRLNA---EIPVHQPLEPDVRSRMDQLQIGNIT----SAVRFMEDVGTHYVNSYTTGNSLYQVFVYSRKNYSMI(49)
IB3089A      Hs YREFARWKVRNTAIERRDLVRHPVPLMPEFQRSIRLLGRRPTTQ------QFIDTIIKKYGTHLLISATLGGEEALTMYMDKSRLDRK(29)
consensus/80%   ........hp...b..p........l...b.pshp.lspp.p.s........b..bbppaGTHbl.pspbGub....h.b.p.ph...
2-structure/PHD   EEEEEEEEeEEEEEe       hhhHHHHHHHHHH            hHHHHHHHHH    EEEEEe   eEEEEEEe
CT153        Ct SHTVFLGG(10)LDFKDWSESVHLE--PVPIQV-SLQPITNLLVPLHFPNIGAAELSNKRESLQQAIRVYLK 3328555 427-621
CT153        Cp AQTVFLGG(10)LDFKDWSESIPNE--PIPLAI-SVSSITDLIIPELFPSEDAQVLSQKKSALGQVILNYLE 4376445  32-226
Perforin     Mm RHVEVLGG(16)EQFSTWTASLPSN--PGLVDY-SLEPLHTLLEEQ----------NPKREALRQAISHYIM  129820 165-368
Perforin     Hs RHSEVVGG(16)EQYSAWVNSLPGS--PGLVDY-TLEPLHVLLDSQ----------DPRREALRRALSQYLT  129819 166-369
Compl. C6    Hs SISLIRGG(19)KTFSEWLESVKEN--PAVIDF-ELAPIVDLVRNIP-------CAVTKRNNLRKALQEYAA 4559406 312-516
Compl. C7    Hs GEPFIRGG(20)RRYSAWAESVTNL--PQVIKQ-KLTPLYELVKEVP-------CASVKKLYLKWALEEYLD 4557387 249-450
Compl. C8a   Hs IISRVRGG(14)ITYRSWGRSLKYN--PVVIDF-EMQPIHEVLRHTSLG-----PLEAKRQNLRRALDQYLM 4557389 288-492
Compl. C8b   Hs LVVLVRGG(16)DLMQEWGDAVQYN--PAIIKV-KVEPLYELVTATDFA-----YSSTVRQNMKQALEEFQK 4557391 291-498
Compl. C9    Hs VVSLIRGG(20)TDFVNWASSINDA--PVLISQ-KLSPIYNLVPVKMK------NAHLKKQNLERAIEDYIN 4502511 293-503
T22A6.120    At ADTSSLGS(21)LMHNEWLQTVQME--PDVISM-SFIPITSLLNGV-----------PGSGFLSHAINLYLR 5051771 125-320
Mpg-1        Mm SRVQSFGG( 6)ITLETWQKGITNH--LVAIDR-AGLPLHFFIKPDKLPGLPGPLVKKLSKTVETAVRHYYT 2137564 143-342
SpoC1-C1C    En SKCSVMGG(15)RLFSQWIRSIGASGTQDVIHV-LADSIYNFLLRSPNP-----EHKEIGDKIQRASRFHSK  283343 126-320
Apextrin     He PITISLIG(20)ECPSNWARSTIAT--NILTGLKEYANYRGVVPSSDPDVTVPLTWPDGKYALPEAVTLGDN 3378106 160-378
KIAA0634     Hs SDDQLISG(16)LCRRPGKEQLSPT--PVLLEINRVVPLYTLIQDN-----------GTKEAFKSALMSSYW 3327082 833-1017
Astrotactin  Hs GTKRMAAG(16)LCHVTSSPDTPAE--PVLLEVTKAAPIYELVTNN-----------QTQRLLQEATMSSLW 2564326 811-999
Torso-like   Dm QYEYYVVK(11)TLLRSLDSLLGND-AILQLDLKSLKPIFREEPE-------------KESWYHEVLDNNVK  731018 149-343
Hypothetical Hs HHIQIATG(16)YDNLDSVSSVLVQ--SPENKV-QLLGLQVLLPEY------------LRERFVAAALSYIT 4200216  87-279
IB3089A      Hs HEIQISTG(16)YDNLDSVSSVLLQ--STESKL-HLQGLQIIFPQY------------LQEKFVQSALSYIM 3041877  72-251
consensus/80%   ....h.sG    b...ph.psl..p..s..lph.ph.slh.ll................pp.b.pAh..hh.
2-structure/PHD  eEEEEe         hhhhe         ee         ee e             hHHHHHHHHHH Current Biology   
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functions of the C. trachomatis and
C. pneumoniae CT153 MACPF
domains? It is notable that the region
of highest similarity among all
MACPF domains (Figure 1) is
coincident with two predicted
amphipathic α helices, thought to be
the membrane-spanning region of
human complement component 9
[12]. It is considered probable,
therefore, that this region in CT153
interacts with membranes. This
prediction is of particular interest
because the C. trachomatis CT153
gene neighbours a cluster of four
phospholipase D homologue genes
(CT154, CT155, CT157 and CT158)
[4]. It is possible that CT153 assists
in the modification of host cell
phospholipids by C. trachomatis [3,13]
involving these phospholipases D
molecules. The clustering of
C. trachomatis CT153 with
phospholipase D homologue genes,
however, is not conserved in
C. pneumoniae [5].
The current lack of detailed
understanding of the chlamydial
developmental cycle, however,
precludes a definitive prediction of
CT153 function. One possible
function of CT153 is pore formation,
similar to that observed for perforin
and complement C9 [14,15], perhaps
thereby facilitating host cell entry.
Another is molecular mimicry of
perforin and/or MAC, thereby
circumventing host defence
mechanisms [16]. For example,
CT153 might be involved in the
resistance of chlamydia-infected cells
to apoptosis [17] if it were to inhibit
host-derived perforin-mediated
membranolysis. Finally, CT153
might be required during stages of
the C. trachomatis life cycle that are
dependent on bacterial protein
synthesis, including the aggregation
and fusion of inclusions, and the
inhibition of lysosomal fusion [18,19].
In conclusion, C. trachomatis and
C. pneumoniae CT153 are members of
a growing list of non-eukaryotic
genes encoding domains previously
thought to be eukaryote-specific but,
upon more careful analysis, are
detectable in some bacteria [4,20].
These chlamydial genes are
proposed to have arisen from
horizontal transfer from a eukaryotic
source. Such horizontally-transferred
genes probably facilitate adaptation
of the bacterium to the host’s
intracellular environment [21].
Consequently, it is suggested that
CT153 possesses a critical role in the
chlamydial developmental cycle.
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